RAD in stable lung and heart/lung transplant recipients: safety, tolerability, pharmacokinetics, and impact of cystic fibrosis.

MLA

Doyle, R. L., et al. “RAD in Stable Lung and Heart/Lung Transplant Recipients: Safety, Tolerability, Pharmacokinetics, and Impact of Cystic Fibrosis.” The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, vol. 20, no. 3, Mar. 2001, pp. 330–39. EBSCOhost, https://doi.org/10.1016/s1053-2498(00)00232-1.

APA

Doyle, R. L., Hertz, M. I., Dunitz, J. M., Loyd, J. E., Stecenko, A. A., Wong, R. L., Chappell, K. A., Brazelton, T., Kovarik, J. M., Appeldingemanse, S., Dou, L., Smith, H. T., Tudor, D., & Morris, R. E. (2001). RAD in stable lung and heart/lung transplant recipients: safety, tolerability, pharmacokinetics, and impact of cystic fibrosis. The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, 20(3), 330–339. https://doi.org/10.1016/s1053-2498(00)00232-1

Chicago

Doyle, R L, M I Hertz, J M Dunitz, J E Loyd, A A Stecenko, R L Wong, K A Chappell, et al. 2001. “RAD in Stable Lung and Heart/Lung Transplant Recipients: Safety, Tolerability, Pharmacokinetics, and Impact of Cystic Fibrosis.” The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation 20 (3): 330–39. doi:10.1016/s1053-2498(00)00232-1.